POZ - Women Hub : Treatment News

POZ Women / Female Hub
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Women's Hub News

Back to home » News & Views » Treatment News

February 28, 2011
CCR5 Gene Therapy Shows HIV Treatment Potential
February 23, 2011
AIDS Activists Call on Public to Support New FDA HIV Drug Approval Policy
February 22, 2011
New Possibility for Some Heavily Treatment Experienced: Add Reyataz or Invirase
February 17, 2011
Statins Show Promise as Anti-inflammatory Therapies for HIV Infection
February 16, 2011
Best HIV Treatment Practices Among Women Receiving ADAP
February 14, 2011
New Study Says HIV Vaccines Might Not Need to Produce Protective Blood Antibodies
February 11, 2011
Gilead and Tibotec’s Combo HIV Drug Is Back on Track
February 10, 2011
FDA Puts a Hold on Development of ViiV HIV Drug
February 09, 2011
Math Wizards Develop New HIV Drug Candidates
February 08, 2011
New Cure-Related Research: Antabuse to Flush HIV Reservoir
February 07, 2011
New Reyataz Dosing Recommendations for HIV-Positive Pregnant Women
February 04, 2011
HIV-Positive Men Who Bareback Should Have More Frequent Hep C Testing
February 03, 2011
Clinical Trial of Triple-Drug Combination Pill 572-Trii Begins
February 01, 2011
Drug Resistance Shouldn’t Preclude Using NRTIs in an HIV Salvage Regimen


Featured Video
Participants share their stories at the XIX International AIDS Conference. For more on the conference, click here.
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

    New York
    New York


    New York

    New York
Click here to join POZ Personals!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.